← Back to Clinical Trials
Recruiting NCT04939922

China Headache and Vertigo Registry Study

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Headache Disorders, Primary
Sponsor Second Affiliated Hospital, School of Medicine, Zhejiang University
Study Type OBSERVATIONAL
Phase N/A
Enrollment 10,000
Sex ALL
Min Age 4 Years
Max Age 99 Years
Start Date 2017-06-12
Completion 2050-12-12

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

In the Chinese Headache and Vertigo Registration Study, patients aged 4-99 years with headache (primary headache and secondary headache such as migraine and tension type headache), vertigo (vertigo diseases such as vestibular migraine) and chronic pain (fibromyalgia and other diseases) were collected. The biomarkers, imaging features, right-to-left shunt of the heart (lung), genetic characteristics, treatment, and outcome (in relation to other diseases) of headache-related diseases were studied, and long-term follow-up was planned.

Eligibility Criteria

Inclusion Criteria: * Written informed consent and participant privacy information (eg, Written Authorization for Use and Release of Health and Research Study Information) obtained from the participant prior to initiation of any study-specific procedures. * Male or female participants ages 4 to 99 years. * Headache patients meeting the diagnostic criteria for ICHD-3, including primary headaches such as migraine and tension tension-type headaches, secondary headaches. * Patients who meet the headache diagnosis in the ICHD-3 appendix (including vestibular migraine). Exclusion Criteria: * Patients who were unable to complete scales such as headache diary. * Patients denied or unable to be admitted for long-term follow-up.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}